Joinn Laboratories(China)Co.,Ltd. (HKG:6127)

HKG:6127 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	965.2	2,863	2,917	4,154	308.69
Short-Term Investments	-	1,533	-	-	-
Trading Asset Securities	1,396	373.35	408.47	680.98	238.9
Cash & Short-Term Investments	2,361	4,770	3,325	4,835	547.59
Cash Growth	-50.49%	43.44%	-31.23%	782.97%	77.99%
Accounts Receivable	340	340.06	340.1	214.51	157.85
Other Receivables	8.49	11.51	7.59	5.83	8.77
Receivables	348.49	351.57	347.69	220.34	166.62
Inventory	1,479	1,863	2,195	700.59	406.21
Prepaid Expenses	-	0.94	3.32	0.27	-
Other Current Assets	842.84	136.62	57.47	58.21	62.48
Total Current Assets	5,031	7,122	5,928	5,814	1,183
Property, Plant & Equipment	1,502	1,548	1,733	779.12	513.62
Long-Term Investments	91	797.98	2,146	1,536	64.44
Goodwill	138.04	136.01	133.74	122.43	125.3
Other Intangible Assets	298.51	292.38	299.54	137.19	123.63
Long-Term Deferred Tax Assets	33.36	28.25	32.61	43.85	35.26
Long-Term Deferred Charges	63.06	74.89	44.91	30.51	26.42
Other Long-Term Assets	2,239	28.03	46.28	73.21	36.23
Total Assets	9,396	10,027	10,364	8,537	2,108
Accounts Payable	50.22	43.32	127.31	53.64	60.29
Accrued Expenses	127.17	108.6	128.29	78.11	54.05
Current Portion of Long-Term Debt	-	-	3.53	4.54	3.08
Current Portion of Leases	-	27.5	24.01	21.65	-
Current Income Taxes Payable	-	41.35	59.2	21.86	20.3
Current Unearned Revenue	827.16	1,152	1,295	972.21	583.54
Other Current Liabilities	106.01	94.62	207.21	62.22	38.79
Total Current Liabilities	1,111	1,467	1,844	1,214	760.04
Long-Term Debt	-	-	3.28	4.94	21.38
Long-Term Leases	21.6	41.92	56.89	64.19	-
Long-Term Unearned Revenue	67.92	74.49	80.68	60.84	67.04
Long-Term Deferred Tax Liabilities	116.88	162.34	188.24	48.43	35.2
Total Liabilities	1,317	1,746	2,173	1,393	883.66
Common Stock	749.48	749.89	535.68	381.25	227.45
Additional Paid-In Capital	5,238	5,267	5,480	5,544	249.8
Retained Earnings	2,263	2,308	2,125	1,189	728.49
Treasury Stock	-220.56	-146.45	-53.15	-3.93	-9.92
Comprehensive Income & Other	49.48	100.52	95.56	26.74	29.06
Total Common Equity	8,079	8,279	8,184	7,136	1,225
Minority Interest	0.37	1.72	7.16	8.22	-0.73
Shareholders' Equity	8,079	8,281	8,191	7,144	1,224
Total Liabilities & Equity	9,396	10,027	10,364	8,537	2,108
Total Debt	21.6	69.42	87.71	95.32	24.46
Net Cash (Debt)	2,340	4,700	3,238	4,740	523.14
Net Cash Growth	-50.22%	45.18%	-31.69%	806.03%	83.34%
Net Cash Per Share	3.16	6.28	4.31	6.50	0.84
Filing Date Shares Outstanding	619.45	762.54	749.95	747.24	743.13
Total Common Shares Outstanding	619.45	762.54	749.95	747.24	624.14
Working Capital	3,921	5,655	4,084	4,600	422.87
Book Value Per Share	13.04	10.86	10.91	9.55	1.96
Tangible Book Value	7,642	7,851	7,750	6,877	975.97
Tangible Book Value Per Share	12.34	10.30	10.33	9.20	1.56
Buildings	-	455.95	449.47	371.05	327.64
Machinery	-	581.35	508.43	415.14	351.97
Construction In Progress	-	342.01	277.74	127.36	48.63
Order Backlog	-	3,300	-	-	-

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.